Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.550
+0.020 (1.31%)
At close: Aug 13, 2025, 4:00 PM
1.590
+0.040 (2.59%)
Pre-market: Aug 14, 2025, 8:48 AM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $53.59 million as of August 14, 2025. Its market cap has increased by 102.77% in one year.
Market Cap
53.59M
Enterprise Value
47.57M
1-Year Change
102.77%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $53.59M, a decrease of -57.01%. That is a compound annual growth rate of -17.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 52.89M | -7.68% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 593.10B |
| Johnson & Johnson | 419.89B |
| AbbVie | 355.66B |
| UnitedHealth Group | 246.24B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.11B |